Balázs C, Lévai M, Stenszky V, Farid N R
Acta Med Hung. 1986;43(4):381-7.
T lymphocyte subsets were prospectively examined in the peripheral blood and thyroid aspirates of 10 patients with hyperthyroid Graves' disease before and after treatment with methimazole and attainment of euthyroidism. T lymphocyte subsets were identified with monoclonal antibodies and pattern of alpha-naphthyl-acetate esterase (ANAE) staining pattern in the case of peripheral blood and ANAE staining pattern with thyroid aspirate smears. Before treatment, OKT8+ lymphocytes were significantly decreased (18.4% +/- 4.8) (S. D.) in the patients compared to control (28.8 +/- 6.7%, p less than 0.05), the OKT4/OKT8 ratio was increased (2.92 vs 2.11). Percent OKT8+ lymphocytes were not different from the controls when the ten patients had been rendered euthyroid. ANAE mononuclear cells with a diffuse pattern (presumed suppressor cells) were 4.2% +/- 1.8 before treatment and 8.3 +/- 2.4 (p less than 0.05) after treatment and 11.5% +/- 2.2 in controls. ANAE mononuclear cells with diffuse pattern represented 4.2% +/- 1.8 of the mononuclear cells infiltrating the thyroid gland of untreated patients and rose to 8.3% +/- 2.4 after the patients had become euthyroid. ANAE negative cells (B cells and some T cells) were increased in the thyroid of untreated patients. It is concluded that mononuclear cells with presumed suppressor T cell phenotype are decreased in the blood and thyroid glands of patients with active Graves' disease and that this defect is corrected when euthyroidism has been established.
对10例甲状腺功能亢进的格雷夫斯病患者在接受甲巯咪唑治疗并达到甲状腺功能正常前后,对其外周血和甲状腺穿刺物中的T淋巴细胞亚群进行了前瞻性检测。在外周血检测中通过单克隆抗体鉴定T淋巴细胞亚群,在甲状腺穿刺涂片检测中通过α-萘乙酸酯酶(ANAE)染色模式进行鉴定。治疗前,患者的OKT8 +淋巴细胞显著减少(18.4%±4.8)(标准差),而对照组为(28.8±6.7%,p<0.05),OKT4/OKT8比值升高(2.92对2.11)。当这10例患者甲状腺功能恢复正常时,OKT8 +淋巴细胞百分比与对照组无差异。治疗前,呈弥漫性模式的ANAE单核细胞(推测为抑制细胞)为4.2%±1.8,治疗后为8.3±2.4(p<0.05),对照组为11.5%±2.2。呈弥漫性模式的ANAE单核细胞在未经治疗患者的甲状腺浸润单核细胞中占4.2%±1.8,患者甲状腺功能恢复正常后升至8.3%±2.4。未经治疗患者的甲状腺中ANAE阴性细胞(B细胞和一些T细胞)增加。结论是,活动性格雷夫斯病患者血液和甲状腺中具有推测性抑制性T细胞表型的单核细胞减少,而当甲状腺功能恢复正常时这一缺陷得到纠正。